JAYNE GUNN: Open Payments
NPI 1235478058 · MANHATTAN, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$371 in 15 payments from 7 companies in 2025. Trend: 2023 $290 · 2024 $509 · 2025 $371
Food & beverage: $371
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $172 |
| Novo Nordisk Inc | 4 | $85 |
| PFIZER INC. | 1 | $26 |
| ABBVIE INC. | 1 | $26 |
| Regeneron Healthcare Solutions, Inc. | 1 | $23 |
| Lilly USA, LLC | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
Products named: BREZTRI, Ozempic, AIRSUPRA, ZAVZPRET, VRAYLAR, EVKEEZA, MOUNJARO, GEMTESA.
Industry payments across KS — which companies pay providers there.
